Attract talent

Triplet Therapeutics



Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- a group of more than 50 known genetic diseases including Huntington’s disease, myotonic dystrophy, spinocerebellar ataxias, fragile X syndrome, and familial amyotrophic lateral sclerosis (ALS) -- leveraging insights from patient genetics. Triplet designs and develops potenti...


Add photos to showcase Triplet Therapeutics’s culture


Add Triplet Therapeutics’s values

Insider experiences

Share your experience of working at Triplet Therapeutics

Nessan Bermingham
Founder, President & CEO
Eva Asp
Senior Director, Molecular & Cell Biology
Brian Bettencourt
SVP, Research
Irina Antonijevic
Chief Medical Officer
Pei Ge
Director of Pharmacology
Jeff Cerio
SVP, General Counsel
Alan J. Buckler
Chief Scientific Officer
Peter Bialek
Director of Translational Sciences
W. George Lai
VP, DMPK & Toxicology
Deborah Gouveia
VP, Clinical Operations
Amar Ghodasara
Director, Business Development & Strategy
David Morrissey
SVP, Technology
Amy Lurier
SVP, Talent Acquisition & People
Eric Sullivan
Chief Financial Officer
Jia Tay
Director, Program Management

Add your teams to show how people work together at Triplet Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.